Hexavalent vaccine DTaP/IPV/Hib/HepB: PGD template
PGD template for administering hexavalent vaccine following national recommendations and the routine childhood immunisation programme.
Applies to England
Documents
Details
This patient group direction (PGD) template supports the administration of hexavalent vaccine, DTaP/IPV/Hib/HepB, in accordance with national recommendations and the routine childhood immunisation programme.
DTaP/IPV/Hib/HepB PGD v04.00 is valid from 25 July 2022 to 24 July 2024.
Practitioners must not use this PGD template until it has been authorised in Section 2. This is a legal requirement (see Human Medicines Regulations 2012). Practitioners should follow local policy/procedures to access authorised PGD documents.
This PGD template should be used with reference to current national guidance, the Green Book, and summary of product characteristics for the vaccine.
Last updated 29 July 2022 + show all updates
-
Added v04.00 – see page 2 for change history.
-
Added updated PGD.
-
Replaced PDG template with version v02.00, valid from 1 September 2019 to 31 August 2021.
-
First published.